Related Experiment Videos
[Determination of steroid hormones in material evidence of biological origin by thin-layer chromatography]
Sudebno-Meditsinskaia Ekspertiza
|January 1, 1986
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Measurement of benzodiazepine receptor agonists metabolites and their concentration in urine].
Sudebno-meditsinskaia ekspertiza·2023
[The role of the immunohistochemical investigations in the documentation of intravitality and severity of the gunshot injuries to the soft tissues].
Sudebno-meditsinskaia ekspertiza·2018
[Clinical pathomorphology and tanatogenesis of various forms of alcoholic intoxication].
Sudebno-meditsinskaia ekspertiza·2018
[Hair as a study object in case of poisoning with heavy metal salts].
Sudebno-meditsinskaia ekspertiza·2013
[Protein markers of diabetic retinopathy].
Klinicheskaia laboratornaia diagnostika·2002
[Professional training of specialists in the field of forensic-chemical and chemical-toxicological expertise: key aspects].
Sudebno-meditsinskaia ekspertiza·2026
[On the forensic medical significance of cadaveric imbibition around subcutaneous veins in cases of death from general hypothermia].
Sudebno-meditsinskaia ekspertiza·2026
[The role of magnetic resonance imaging in the diagnosis of diffuse axonal injury].
Sudebno-meditsinskaia ekspertiza·2026
[Electron microscopic characterization of hair damage caused by objects of varying severity].
Sudebno-meditsinskaia ekspertiza·2026
Synergistic lipase inhibition by Garcinia parvifolia metabolites: a 1H NMR-based metabolomic deciphering of ligand interactions.
Metabolomics : Official journal of the Metabolomic Society·2026
Design, synthesis, and evaluation of fluorescent probes targeting DNA polymerase theta (Polθ) for inhibitor screening and cellular imaging.
European journal of medicinal chemistry·2026
Proteolysis Targeting Chimera (PROTAC) Linkerology Enhances the CDK-Degradation Selectivity Profile of a Multi-CDK Inhibitor: Discovery of Potent, Anti-Leukemic CDK9 Degraders.
ACS pharmacology & translational science·2026